This is the second webinar in the BioMedical SIG webinar series, “From Research to Development – Paths to Cross the Valley of Death in Life Sciences”, which showcases initiatives available to European KTOs to maturate technologies with potential in TRL and CRL, without the creation of a spin-off.
In this session, speakers Peter Nussbaumer and Gernot Faustmann will present the KHAN/w4i/LDC initiative. This collaborative drug discovery platform facilitates the translation of world-class science into innovative therapies for the benefit of patients. Their mission is to create value through cooperative drug development partnerships with academic innovators in Europe. They focus on first-in-class therapies for attractive markets with a high unmet medical need.
This webinar is organised by the BioMedical SIG and supported by UCB. Join the BioMedical SIG to stay informed.
The new website signals this pioneering, resonating role and is a tribute to the many accomplishments and innovations European TTO’s have generated and implemented over many years, thus strengthening both our economy and society.
Koenraad Debackere
KU Leuven, Belgium
ASTP's conference helped us to network with decision-makers in the technology transfer industry and provides a great platform to discuss future innovation in this sector.
Christopher Römer
Inventtory, Germany
Thank you for such enjoyable inspiring event, great choice of the lecturers!!!
Linda Ondrackova
University of Pardubice, Czech Republic
Was great to meet counterparts in my profession who may share my experiences, but who may also have other ideas and approaches.
Tim Moser
Netherlands Cancer Institute, Netherlands
This course gives an in-depth understanding on managing contract portfolio, including research contracts, license agreements, and other collaboration agreements.
Ram Siddappa
Erasmus MC, Netherlands
Join our newsletter and get the latest news